Lexston Life Sciences Corp
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. It holds a 100% interest in the Dory property consisting of four non-surveyed contiguous mineral claims totaling 1,348 hectares located within the Alberni Mining Division of British Columbia. The company is based in Vancouver, Canada.
Lexston Life Sciences Corp (LEXTF) - Total Assets
Latest total assets as of November 2025: $925.87K USD
Based on the latest financial reports, Lexston Life Sciences Corp (LEXTF) holds total assets worth $925.87K USD as of November 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Lexston Life Sciences Corp - Total Assets Trend (2021–2024)
This chart illustrates how Lexston Life Sciences Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Lexston Life Sciences Corp - Asset Composition Analysis
Current Asset Composition (May 2024)
Lexston Life Sciences Corp's total assets of $925.87K consist of 60.4% current assets and 39.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 52.0% |
| Accounts Receivable | $1.09K | 0.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Lexston Life Sciences Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lexston Life Sciences Corp's current assets represent 60.4% of total assets in 2024, a decrease from 89.6% in 2021.
- Cash Position: Cash and equivalents constituted 52.0% of total assets in 2024, down from 86.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 0.2% of total assets.
Lexston Life Sciences Corp Competitors by Total Assets
Key competitors of Lexston Life Sciences Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Galileo Resources Plc
LSE:GLR
|
UK | GBX14.28 Million |
|
Shenzhen Zhongjin Lingnan Nonfemet Co Ltd
SHE:000060
|
China | CN¥48.31 Billion |
|
Shengda Mining Co Ltd
SHE:000603
|
China | CN¥7.11 Billion |
|
Pangang Group Vanadium Titanium & Resources Co Ltd
SHE:000629
|
China | CN¥14.74 Billion |
|
China Tungsten and Hightech Materials Co Ltd
SHE:000657
|
China | CN¥20.78 Billion |
|
Guocheng Mining Co Ltd
SHE:000688
|
China | CN¥8.41 Billion |
|
China Nonferrous Metal Industry’s Foreign Engineering and Construction Co Ltd
SHE:000758
|
China | CN¥23.09 Billion |
|
Huludao Zinc Industry Co Ltd
SHE:000751
|
China | CN¥10.04 Billion |
Lexston Life Sciences Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Lexston Life Sciences Corp generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Lexston Life Sciences Corp is currently not profitable relative to its asset base.
Lexston Life Sciences Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.78 | 2.53 | 8.51 |
| Quick Ratio | 2.78 | 2.53 | 8.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $247.10K | $ 289.67K | $ 937.92K |
Lexston Life Sciences Corp - Advanced Valuation Insights
This section examines the relationship between Lexston Life Sciences Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.13 |
| Latest Market Cap to Assets Ratio | 1.74 |
| Asset Growth Rate (YoY) | -7.8% |
| Total Assets | $750.95K |
| Market Capitalization | $1.31 Million USD |
Valuation Analysis
Above Book Valuation: The market values Lexston Life Sciences Corp's assets above their book value (1.74 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Lexston Life Sciences Corp's assets decreased by 7.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Lexston Life Sciences Corp (2021–2024)
The table below shows the annual total assets of Lexston Life Sciences Corp from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-05-31 | $750.95K | -7.78% |
| 2023-05-31 | $814.30K | -14.54% |
| 2022-05-31 | $952.80K | -13.60% |
| 2021-05-31 | $1.10 Million | -- |